Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Alpha-lipoic Acid Adjunctive Therapy in Schizophrenia: A Randomized, Double-blind, Placebo-controlled Trial

NCT03788759 is registered in ClinicalTrials.gov with Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara as lead sponsor.

NCT NCT03788759
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03788759 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Alpha-lipoic Acid Adjunctive Therapy in Schizophrenia: A Randomized, Double-blind, Placebo-controlled Trial
Lead sponsor
Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara
Phase
Phase 2/3
Overall status
Completed
Start date
September 1, 2019
Completion date
December 1, 2021
Enrollment
48 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

oxidative stress, schizophrenia